BDBM360595 1-(2,3-dichlorophenyl)-3-((5-(3,5- dimethoxyphenyl)isoquinolin-8- yl)methyl)urea::US9828369, Example 152
SMILES: COc1cc(OC)cc(c1)-c1ccc(CNC(=O)Nc2cccc(Cl)c2Cl)c2cnccc12
InChI Key: InChIKey=GYISCEYLQYIQRR-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360595![]() (1-(2,3-dichlorophenyl)-3-((5-(3,5- dimethoxyphenyl...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 198 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair |